Nishta Jankee Ramjee

Nishta Jankee Ramjee

Auto-generated profile, based on publicly available information

Nishta Jankee Ramjee

Oxford Heart Centre, Oxford University Hospitals NHS Trust , Headley Way, Oxford, OX3 9DU

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 July 2026 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
BBBenjamin Mothibe Bussmann
Benjamin Mothibe Bussmann
NJNicholas Johnson
Nicholas Johnson
NRNishta Jankee Ramjee
Nishta Jankee Ramjee
TMTabassum Musharrat
Tabassum Musharrat
SKSamuel Krasner
Samuel Krasner
TCThomas J Cahill
Thomas J Cahill
Background: Cardiac damage (CD) is prevalent across the spectrum of aortic stenosis (AS) and is a strong predictor of adverse outcomes. The natural history of CD in early AS and drivers of its progression, are poorly defined. We aimed to identify predictors and the prognostic significance of CD progression in patients with non-severe AS. Methods: This was a single centre cohort study with longitudinal follow-up. Patients with mild or moderate AS at baseline and over serial echocardiographic follow-up were evaluated for the presence and progression of CD over time. Results: 1751 patients were included. At baseline, CD was present in 1320 (75%), categorized as stage 1 in 231 (13%), stage 2 in 672 (38%), stage 3 in 109 (6%) and stage 4 in 308 (18%). Over a median follow-up of 2.1 [Q1–Q3 1.1-3.6] years, the prevalence of advanced-stage (stages 3 and 4) CD increased from 24% to 30%. Factors associated with progression to advanced-stage CD included comorbidity burden (adjusted OR [aOR] 1.23 per additional comorbidity; 95% CI: 1.10–1.38; p < 0.001) and the presence of atrial fibrillation (aOR 3.23; 95% CI: 1.15–9.07, p = 0.024) or left atrial dilation (aOR 1.55; 95% CI: 1.11–2.16, p = 0.010)], but not AS severity. Progression of CD was independently associated with all-cause mortality (adjusted HR [aHR] 1.35; 95% CI: 1.07–170; p = 0.012). Conclusions: In non-severe AS, CD is common and frequently progresses over time. CD progression appears to be driven by comorbidities and pre-existing myocardial remodelling and is an independent predictor of all-cause mortality.

28 July 2026 in Kidney International Case Reports
Verified
Journal Article
Open access
NRNishta Jankee Ramjee
Nishta Jankee Ramjee
JRJaykrishan Ramjee
Jaykrishan Ramjee
UAUmair Asad
Umair Asad
HSHowida Shawki
Howida Shawki
OWOlivia Worthington
Olivia Worthington
ISInnocent Lule Segamwenge
Innocent Lule Segamwenge